The OASIS: Scoring, the 8-Point Cutoff, and Clinical Use

The Overall Anxiety Severity and Impairment Scale (OASIS) was developed by Sonya Norman, Shadha Cissell, Adrienne Means-Christensen, and Murray Stein, and published in 2006 in Depression and Anxiety. The problem it addressed is familiar to anyone running an anxiety caseload. The field had solid severity measures for individual diagnoses and almost nothing short that worked across all of them at once.

Their solution was to drop diagnosis-specific content entirely. The five items ask about the anxiety itself: how often it showed up, how strong it got, and what it stopped the person from doing. A client with panic disorder, a client with social anxiety, and a client carrying both answer the same five questions, and their totals mean the same thing.

That design makes the OASIS transdiagnostic in the practical sense. One instrument tracks severity and impairment for any anxiety presentation, including mixed ones, and you do not switch forms when the working diagnosis changes.

The scale is free for clinical use, which helped it move quickly from the validation literature into routine practice. The free OASIS screening hosted here scores the standard five items in the browser.

Internal consistency runs around .80, respectable for five items that cover severity and impairment together. The items behave as a single factor, so the total is the score. There is nothing to subscale and nothing to reverse.

The cutoff comes from Campbell-Sills et al. (2009), published in the Journal of Affective Disorders. In a primary care sample, a total of 8 or above discriminated anxiety-disorder cases from non-cases with a sensitivity of 0.89 and a specificity of 0.71.

Those two numbers should be read together. A sensitivity of 0.89 means the OASIS misses few genuine cases. A specificity of 0.71 means roughly three in ten people without an anxiety disorder will screen positive anyway. That trade is the right one for primary care, where missing a case costs more than an extra clinical conversation, and it explains why a score of 9 is a reason to ask further questions instead of a verdict.

All five items refer to the past week and use the same five-point scale from 0 to 4. The original instrument gives each item its own anchor wording; implementations that use a uniform ladder from None to Extreme preserve the same 0 to 4 numeric scoring used clinically.

The items cover, in order: how often the person felt anxious, how intense the anxiety was when it hit, how often they avoided situations, places, objects, or activities because of anxiety or fear, how much anxiety interfered with what they needed to do at work, school, or home, and how much it interfered with their social life and relationships.

Add the five responses for a total between 0 and 20. No weighting, no conversion, no reverse-scored items.

A total of 8 or above is the validated cutoff for probable clinically significant anxiety. The bands on this site read: 0-7 Below Threshold, 8-11 Mild Clinical Anxiety, 12-15 Moderate Clinical Anxiety, 16-20 Severe Clinical Anxiety.

The OASIS screens; it does not diagnose. A total at or above 8 says the person's anxiety severity and impairment resemble the pattern seen in anxiety disorders and that a diagnostic interview is warranted. It says nothing about which disorder, which is deliberate, and nothing about duration, medical contributors, substance effects, or trauma history. A score below 8 in someone describing real impairment deserves the same follow-up conversation. The number never overrides what the client is telling you.

Compare it to the GAD-7, the instrument most clinicians reach for first. The GAD-7 was built around generalized anxiety disorder and its items read that way: worrying too much about different things, trouble relaxing, being unable to stop worrying. It screens usefully for other anxiety disorders and it is a good measure. Ask it to track a client whose main problem is driving avoidance after a car accident, or a teenager who cannot eat in the school cafeteria, and it starts measuring around the edges of the actual problem.

The OASIS asks about the anxiety instead of the diagnosis, so it holds still while the formulation moves. When a presentation is panic in March and social avoidance by June, the same five numbers stay comparable across the whole course of treatment. For clients carrying more than one anxiety disorder, closer to the norm than the exception in outpatient work, one total covers the picture that would otherwise take three forms.

Three of the five items measure something severity-only scales leave out: avoidance, interference with work, school, or home responsibilities, and interference with social life. A client who has organized their life so carefully around a fear that the fear rarely fires will report low distress while their world quietly shrinks. The OASIS catches that pattern, because avoidance and impairment account for 12 of the 20 available points.

The practical payoff is brevity. Five items with a one-week window can go to a client in the waiting room every session without becoming a chore, and the window does not overlap the way it does with two-week instruments used weekly. That makes the OASIS one of the few validated anxiety measures that genuinely fits session-by-session tracking. The trade is resolution: five items give a coarser reading than a 20-item disorder-specific scale, so for a client in exposure treatment for one clearly defined phobia, a targeted measure will still register movement the OASIS misses.

Initial screening: administered at the first session, the OASIS gives a severity and impairment baseline before the diagnosis is settled, which fits the reality of intake, where the differential is usually still open. Pairing it with the PHQ-9 covers the two most common presenting complaints in about two minutes of client time.

Session-by-session monitoring: the past-week window lines up exactly with a weekly session schedule. Handing it over in the waiting room and reading the total before the hour starts turns the opening minutes into something specific. The score went from 14 to 11, so what was different this week?

Meaningful change: watch the cutoff first. A client who moves from 13 to 7 has crossed from the moderate band to below threshold, and that is a different kind of progress from moving 17 to 13 inside the clinical range. Direction and band crossings carry more information than any single point difference, and a one-point wobble week to week is noise.

Measurement-based care: because the OASIS includes impairment, it answers a question severity scales cannot. A client whose anxiety intensity has barely budged while their avoidance and interference items have dropped from 3s to 1s is improving in exactly the way exposure treatment is supposed to work, and the total reflects it. Charting the five item scores alongside the total, rather than the total alone, makes that pattern visible.

0-7 (Below Threshold): scores here fall under the validated cutoff of 8, so the person's anxiety sits at a level more typical of people without an anxiety disorder. No further anxiety-specific evaluation is indicated on the basis of the number alone. In monitoring, dropping into this range during treatment is the clearest single marker of response the instrument offers and a reasonable point to start discussing maintenance and relapse prevention. Read the item pattern anyway: a 7 built almost entirely from avoidance and interference tells a different story from a 7 spread evenly across all five.

8-11 (Mild Clinical Anxiety): this band opens at the cutoff, so every score in it is a positive screen. An 8 clears the threshold by one point and is worth confirming with a second administration or a careful interview, while an 11 is a solid positive. Typical next steps are a diagnostic interview to identify which anxiety presentation is driving the score, psychoeducation, and a first course of skills work. Many clients in this band respond well to CBT alone.

12-15 (Moderate Clinical Anxiety): anxiety in this range is usually interfering visibly with work or school and with relationships, since totals this high require the impairment items to be endorsed at 2 or 3. Active treatment is generally indicated. Structured exposure-based therapy, medication, or the combination are first-line considerations depending on presentation, history, and client preference. Weekly administration earns its place here, because it shows within a few sessions whether the plan is moving anything.

16-20 (Severe Clinical Anxiety): a total this high means near-ceiling responses across most items, so frequent and intense anxiety plus substantial avoidance and impairment in both work and social domains. Combined treatment and closer follow-up intervals are typical. Assess for panic, for substance use as self-management, and for comorbid depression, since anxiety at this level rarely travels alone. Ask directly about safety as well, because severe anxiety with heavy impairment is a risk context and the OASIS contains no risk item.

Is an OASIS score of 8 high? An 8 sits exactly at the validated cutoff, the point where Campbell-Sills et al. (2009) established a sensitivity of 0.89 and a specificity of 0.71 for identifying anxiety-disorder cases. It is the lowest total that counts as a positive screen, and it falls at the bottom of the Mild Clinical Anxiety band. Treat it as the start of a diagnostic conversation. Given that specificity, a meaningful share of people scoring right at 8 will turn out to have no anxiety disorder, and only the interview settles that.

What does an OASIS score of 14 mean? A 14 falls in the moderate band, two points below severe. It describes anxiety that is frequent, strong enough to be distressing, and interfering with daily responsibilities or social life. The number carries no diagnosis by itself; it summarizes severity and impairment over the past week and should be read next to a clinical interview, the client's history, and the specific fears and avoidance behaviors the five items are compressing into one figure.

How often should the OASIS be re-administered? Its items ask about the past week, so weekly administration measures a clean, non-overlapping window and session-by-session use is legitimate in a way it is not for two-week instruments like the PHQ-9 and GAD-7. Every session during active treatment and monthly during maintenance are both defensible. Keep the interval constant either way, since totals gathered over different windows are not really comparable.

OASIS or GAD-7, which one should I use? Use the GAD-7 when the working diagnosis is generalized anxiety and you want items aligned to those criteria, or when you need the instrument that primary care physicians and payers already recognize. Use the OASIS when the presentation spans several anxiety disorders, when the diagnosis is still open, or when avoidance and functional impairment are the treatment targets. Running both at intake costs about three minutes and settles the question with data instead of preference.

Does a score of 8 or above mean the client has an anxiety disorder? No. A positive screen means the severity and impairment resemble what is seen in anxiety disorders and that a diagnostic interview is warranted. It does not identify which disorder, and it cannot rule out the medical, substance-related, and trauma-related explanations that produce similar answers. Hyperthyroidism, stimulant use, and withdrawal states all push these totals up.

Can the OASIS be used with clients who have more than one anxiety diagnosis? Yes, and that is the case it was designed for. Because no item names a diagnosis, a client with both panic disorder and social anxiety produces a single interpretable total instead of two partial pictures. The same holds when the formulation shifts mid-treatment: the numbers stay comparable across the change, which is hard to manage when every new diagnosis brings its own form and its own baseline.

Norman, S. B., Cissell, S. H., Means-Christensen, A. J., and Stein, M. B. (2006). Development and validation of an Overall Anxiety Severity And Impairment Scale (OASIS). Depression and Anxiety, 23(4), 245-249.

Campbell-Sills, L., Norman, S. B., Craske, M. G., Sullivan, G., Lang, A. J., Chavira, D. A., Bystritsky, A., Sherbourne, C., Roy-Byrne, P., and Stein, M. B. (2009). Validation of a brief measure of anxiety-related severity and impairment: The Overall Anxiety Severity and Impairment Scale (OASIS). Journal of Affective Disorders, 112(1-3), 92-101.

Spitzer, R. L., Kroenke, K., Williams, J. B. W., and Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092-1097.